Loading…
Reported covered position: Demetrious Kouzoukas, Carla DiBlasio
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Medical Device Nonvisual Accessibility Act of 2023
Client: DEXCOM, INC. · Firm: DEXCOM, INC.
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
Medical Device Nonvisual Accessibility Act of 2023
Client: DEXCOM, INC. · Firm: DEXCOM, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2024 · third_quarter · Q3
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
Medical Device Nonvisual Accessibility Act of 2023
Client: DEXCOM, INC. · Firm: DEXCOM, INC.
CGM Coverage policy Issues related to the sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: DEXCOM, INC. · Firm: DEXCOM, INC.
CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: DEXCOM, INC. · Firm: DEXCOM, INC.
CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: DEXCOM, INC. · Firm: DEXCOM, INC.
CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
CGM Coverage policy Issues related to the sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
2024 · second_quarter · 2A
CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · 1A
CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act
CGM Coverage policy Issues related to the sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Q2
CGM Coverage policy
CGM Coverage policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Q1
CGM Coverage policy
CGM Coverage policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Q4
Coverage policies for advanced diabetes technology
Coverage Policies for advanced diabetes technology
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Q2
Coverage Policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Q4
Semiconductor challenges/ Supply Chain
Filing targets: Commerce, Dept of (DOC)
2022 · third_quarter · Q3
Semiconductor challenges for Medical Devices
Diabetes device coverage policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC)
2022 · second_quarter · Q2
CMS Coverage Policies for Advanced Diabetes Technologies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Q1
CMS Coverage Policy for advanced diabetes technology
Coverage policy for advanced diabetes technology
2021 · fourth_quarter · 4A
Coverage policy for advanced diabetes technology
CMS Coverage Policy for advanced diabetes technology
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
2021 · fourth_quarter · 4A
Coverage policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC)
2021 · fourth_quarter · Q4
Coverage policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC)
2021 · third_quarter · Q3
Coverage policy for advanced diabetes technology
CMS Coverage Policy for advanced diabetes technology
2021 · second_quarter · Q2
CMS Coverage policy for diabetes technology
CMS Covwreage Policy for Diabetes Technology
Filing targets: Centers For Medicare and Medicaid Services (CMS)
2021 · first_quarter · Q1
Coverage Policy and Criteria
CMS Coverage Policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Q4
CMS Coverage Policy Issues for Continuous Glucose Monitoring
Filing targets: Centers For Medicare and Medicaid Services (CMS)
2020 · third_quarter · Q3
Medicare Coverage Policy
Filing targets: Centers For Medicare and Medicaid Services (CMS)
2020 · second_quarter · Q2
Diabetes Technology Coverage Issues- CMS Waivers
Filing targets: Centers For Medicare and Medicaid Services (CMS)
2019 · fourth_quarter · Q4
CMS CGM Reimbursement
CGM Reimbursememnt
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
2019 · third_quarter · Q3
CMS Coverage Policies and Reimbursement
CMS Coverage Policy and Reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS)
2019 · first_quarter · Q1
CMS Coverage Policy for patient access issues
CMS Coverage Policy Issues for patient access
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Q2
Medicare Coverage Policy Language for Continuous Glucose Monitoring
Coverage Policy of therapeutic continuous glucose monitoring
Filing targets: Office of Management & Budget (OMB), SENATE
2018 · first_quarter · Q1
Coverage policy for therapeutic continuous glucose monitoring
Coverage policy for therapeutic continuous glucose monitoring
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2017 · fourth_quarter · Q4
Coverage policy for therapeutic continuous glucose monitoring equipment
Current coverage policy for therapeutic continuous glucose monitoring systems
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · 3A
Coverage determination challenges for therapeutic CGM
Filing targets: Centers For Medicare and Medicaid Services (CMS)
2017 · third_quarter · RR
CMS Coverage Issues, Technology development in health care
CMS Coverage Issues, Technology development in health care
CMS Coverage Issues, Technology development in health care
CMS Coverage Issues, Technology development in health care
CMS Coverage Issues, Technology development in health care
CMS Coverage Issues, Technology development in health care